Company intelligence / Profile preview

Tegus

Chicago, Illinois, United Statestegus.com ↗

Ownership: Private
Development stage: Other

Overview

Tegus is an investment research platform that provides access to expert perspectives, financial data, and analytics for investors. It offers a large library of expert call transcripts, direct access to company KPIs and models, and tools for managing the investment research workflow. In June-July 2024, it was acquired by AlphaSense to expand their combined market intelligence offerings. There are no clinical results or drug development activities.

Industry: Investors

Partnerships

Now integrated with AlphaSense's content and technology suite

Beyond the preview

Go deeper on Tegus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tegus.

Explore the full profile